We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The antidepressant drug, sertraline, hinders bone healing and osseointegration in rats' tibiae.
- Authors
Abu Nada, Lina; Al Subaie, Ahmed; Mansour, Alaa; Wu, Xixi; Abdallah, Mohamed‐Nur; Al‐Waeli, Haider; Ersheidat, Ala'; Stone, Laura S.; Murshed, Monzur; Tamimi, Faleh
- Abstract
Aim: Selective serotonin reuptake inhibitors (SSRIs) are one of the most common antidepressant drugs. SSRI use is associated with increased risk of bone fracture and titanium implant failure. The aim of this in vivo study was to investigate the effect of SSRIs on osseointegration and bone healing. Materials and Methods: On a total of 24 Sprague‐Dawley rats, a custom‐made titanium implant was placed in the left tibia, while a unicortical defect was created in the right tibia. Rats were assigned randomly into two groups and received a daily dose of either sertraline (5 mg/kg) or saline. After two weeks, they were euthanized and bone healing and osseointegration were assessed by micro‐CT and histology. Results: Bone formation in bone defects was significantly lower (p < 0.05) in sertraline‐treated rats (BV/TV = 20.67 ± 11.98%) compared to the controls (BV/TV = 37.87 ± 9.56%). Furthermore, the percentage of osseointegration was significantly lower (p < 0.05) in sertraline‐treated rats (34.40 ± 7.17%) compared to the controls (54.37 ± 8.58%). Conclusion: Sertraline hinders bone healing and implant osseointegration.
- Subjects
ANTIDEPRESSANTS; FRACTURE healing; SERTRALINE; OSSEOINTEGRATION; TIBIA surgery; ANIMAL experimentation; BONE growth; COMPUTED tomography; PHYSIOLOGIC salines; SEROTONIN uptake inhibitors; TIBIA; TITANIUM; PHARMACODYNAMICS
- Publication
Journal of Clinical Periodontology, 2018, Vol 45, Issue 12, p1485
- ISSN
0303-6979
- Publication type
Article
- DOI
10.1111/jcpe.13015